MYBL2 and breast neoplasm: We studied differentiation using nine genes (ZIC1, TCF7L1, KLF5, MYBL2, NFE2L3, TEAD4, ILF3, HMGA1, HMGB3), which overexpressed in poorly differentiated bladder, glioblastoma, and breast tumors [23].